Quarterly report · Q2
7634.TEDINET S100PKVO
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥12.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥806m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥613m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥828m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥625m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥828m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥627m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥560m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥421m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥564m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥426m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥20.2bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥20.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥19.3bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.0bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥14.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥13.9bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.9bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.8bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.6bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥816m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥902m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥230m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥690m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥240m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥483m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥937m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥455m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥180.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥105.27 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥358.33 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.39 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.45 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 73.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.1% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥617m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥617m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥84m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥448m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥448m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.9bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥402m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥588m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥545m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥103m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥193m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥178m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥178m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥19m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥5.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥721m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥43m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥806m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥654m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥654m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥86m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥418m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥418m |
| jpcrp040300-q2r_E03330-000Care Welfare Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥19m |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q2r_E03330-000Home Medical Treatment Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥217m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥326m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥281m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥45m |
| jpcrp040300-q2r_E03330-000Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥42m |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E03330-000Medical Gas Relatedreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥244m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥181m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥181m |
| jpcrp040300-q2r_E03330-000Nursing Homereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥4m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥5.3bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥5.3bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥45m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥527m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥6.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥5.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥45m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥613m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 489
| Item | Context | Value | Unit |
|---|---|---|---|
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2022-09-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)株主としての権利内容に制限のない、標準となる株式であり、単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)星医療酸器取引先持株会 | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)東京都足立区入谷七丁目11番18号 | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Text · Plus | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)一星社株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)埼玉県さいたま市見沼区大谷1144番地の４ | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)星 幸 男 | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)埼玉県川口市 | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)星 孝 子 | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)東京都中央区 | |
| Name major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)光通信株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No6MajorShareholdersMember | Original text (Japanese)東京都豊島区西池袋一丁目４番10号 | |
| Name major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)星 昌 成 | |
| Address major shareholders | CurrentQuarterInstant_No7MajorShareholdersMember | Original text (Japanese)東京都千代田区 | |
| Name major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)星医療酸器従業員持株会 | |
| Address major shareholders | CurrentQuarterInstant_No8MajorShareholdersMember | Original text (Japanese)東京都足立区入谷七丁目11番18号 | |
| Name major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)榎 本 誠 | |
| Address major shareholders | CurrentQuarterInstant_No9MajorShareholdersMember | Original text (Japanese)埼玉県越谷市 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |